You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TRANSCEND_CLL_004

Showing 1 - 21 of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Small Lymphocytic Trial in United States (JCAR017 (lisocabtagene maraleucel),

Active, not recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Lymphoma, Small Lymphocytic
  • JCAR017 (lisocabtagene maraleucel)
  • +2 more
  • Birmingham, Alabama
  • +63 more
Nov 21, 2022

B-cell Chronic Lymphocytic Leukemia Trial in Peking (Alemtuzumab)

Suspended
  • B-cell Chronic Lymphocytic Leukemia
  • Alemtuzumab
  • Peking, Beijing, China
    Peking University Cancer Hospital
Jun 15, 2022

Atrial Fibrillation, Supraventricular Arrhythmia, Ventricular Arrhythmias and Cardiac Arrest Trial in New Hyde Park (Medtronic

Recruiting
  • Atrial Fibrillation
  • +4 more
  • Medtronic LINQ-2 Insertable Cardiac Monitor (ILR)
  • New Hyde Park, New York
    Northwell (Northshore University/Long Island Jewish Hospitals)
Dec 1, 2022

B-cell Lymphoid Malignancies Trial in Australia, Korea, Republic of, United States (Zanubrutinib, Obinutuzumab)

Completed
Has Results
  • B-cell Lymphoid Malignancies
  • Fort Myers, Florida
  • +14 more
Mar 1, 2022

Refractive Errors Trial in Johns Creek (LID011121 contact lens, Comfilcon A contact lens)

Completed
Has Results
  • Refractive Errors
  • LID011121 contact lens
  • Comfilcon A contact lens
  • Johns Creek, Georgia
    Alcon Investigative Site
Jul 6, 2021

A Disease Registry of Patients With Mantle Cell Lymphoma

Active, not recruiting
  • Mantle Cell Lymphoma
    • Montgomery, Alabama
    • +33 more
    Oct 28, 2022

    Chronic Lymphocytic Leukemia (CLL) Trial in Sparta (High phenolic EVOO intake, No High phenolic EVOO intake)

    Completed
    • Chronic Lymphocytic Leukemia (CLL)
    • High phenolic EVOO intake
    • No High phenolic EVOO intake
    • Sparta, Lakonias, Greece
      University of Peloponnese, School of Health Sciences, Department
    Dec 28, 2019

    Leukaemia, Lymphocytic, Chronic Trial in Worldwide (OFC Infusion, FC infusion)

    Completed
    Has Results
    • Leukaemia, Lymphocytic, Chronic
    • OFC Infusion
    • FC infusion
    • Boca Raton, Florida
    • +134 more
    Jun 5, 2020

    Open Angle Glaucoma Trial in Worldwide (CyPass Micro-Stent, Viscoelastic)

    Completed
    Has Results
    • Open Angle Glaucoma
    • CyPass Micro-Stent
    • Viscoelastic
    • Lubeck, Germany
    • +5 more
    May 29, 2019

    Primary Mediastinal B-cell Lymphoma, Diffuse, Large B-cell Lymphoma, DLBCL Transformed From Follicular Lymphoma Trial run by the

    Completed
    Has Results
    • Primary Mediastinal B-cell Lymphoma
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 29, 2021

    Multiple Sclerosis Trial in United States (Ublituximab, Placebo)

    Completed
    Has Results
    • Multiple Sclerosis
    • Ublituximab
    • Placebo
    • Phoenix, Arizona
    • +11 more
    Jun 22, 2021

    Heart Failure Trial in Maputo, Manila, Kampala (inactivated trivalent influenza vaccine, Sterile saline)

    Completed
    • Heart Failure
    • inactivated trivalent influenza vaccine
    • Sterile saline
    • Maputo, Mozambique
    • +2 more
    Oct 25, 2018

    Heart Failure, Influenza Trial in Worldwide (Sterile saline, inactivated trivalent influenza vaccine)

    Unknown status
    • Heart Failure
    • Influenza
    • Sterile saline
    • inactivated trivalent influenza vaccine
    • Douala, Cameroon
    • +12 more
    Oct 25, 2018

    Leukemia, Lymphoma Trial in Beijing (Anti-CD19-CAR ?dT)

    Unknown status
    • Leukemia
    • Lymphoma
    • Anti-CD19-CAR γδT
    • Beijing, China
      Beijing DOING Biomedical Co., Ltd
    Sep 1, 2017

    Indolent Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia Trial in Canada (Bendamustine at a dose of 100 mg/m2, Bendamustine

    Completed
    Has Results
    • Indolent Non-Hodgkin's Lymphoma
    • Chronic Lymphocytic Leukemia
    • Bendamustine at a dose of 100 mg/m2
    • Bendamustine at a dose of 120 mg/m2
    • Calgary, Alberta, Canada
    • +15 more
    Jun 29, 2017

    Multiple Sclerosis Trial in Worldwide (Ofatumumab 3mg, Ofatumumab 30mg, Ofatumumab 60mg)

    Completed
    Has Results
    • Multiple Sclerosis
    • Ofatumumab 3mg
    • +3 more
    • Cullman, Alabama
    • +60 more
    May 31, 2018

    Chronic Lymphocytic Leukemia Trial in Marseille (Rituximab)

    Unknown status
    • Chronic Lymphocytic Leukemia
    • Marseille, France
      Institut Paoli Calmettes
    Mar 19, 2015

    Chronic Lymphocytic Leukemia Trial in Canada, United States (GX15-070MS)

    Completed
    • Chronic Lymphocytic Leukemia
    • La Jolla, California
    • +4 more
    May 9, 2014

    Chronic Lymphocytic Leukemia Trial in Marseille (Surface expression of functional biomarkers of the NK cell)

    Completed
    • Chronic Lymphocytic Leukemia
    • Surface expression of functional biomarkers of the NK cell
    • Marseille, France
      Institut PAOLI-CALMETTES
    Sep 13, 2011

    Lymphoma, Large B-Cell, Diffuse Trial in Beijing (3D-CRT based Involved Field Radiotherapy)

    Unknown status
    • Lymphoma, Large B-Cell, Diffuse
    • 3D-CRT based Involved Field Radiotherapy
    • Beijing, Beijing, China
      Department of Radiation Oncology, Cancer Hospital, Chinese Acade
    Jul 1, 2010

    Chronic Lymphocytic Leukemia Trial in United States (Infusion of Activated & Expanded Autologous T Cells)

    Completed
    • Chronic Lymphocytic Leukemia
    • Infusion of Activated & Expanded Autologous T Cells
    • San Diego, California
    • +3 more
    Nov 20, 2006